8Cohen M,Gensini GF,Marit F,et al.The safety and efficacy of subcutane-ous enoxaparin versus intravenous unfractionated heparin and tirofibanversus placebo in the treatment of acute ST-segment elevation myocardialinfarction patients ineligible for reperfusion(TETAMI):a randomized trial[J].J Am Coll Cardiol,2003;42(8):1348-61.
3Kimmelstiel C, Badar J, Covic L, et al. Pharmacodynamics and pharmacokinetics of the platelet GP Ⅱb/Ⅲ a inhibitor tirofiban in patients undergoing percutaneous coronary intervention: implications for adjustment of tirofiban and clopidogrel dosage[J]. Thromb Res, 2005,116 : 55.
4Ernst NM, Suryapranata H, Miedema K, et al. Achieved platelet aggregation inhibition after different antiplatelet regimens during percutaneous coronary intervention for ST-segment elevation myocardial infarction[J]. J Am Coll Cardiol, 2004,44 : 1187.
5Wamholtz A,Osmd MA, Heitzer T, et al. Effect of tirofiban on percutaneous coronary intervention -induced endothelial dysfunction in patients with stable coronary artery disease[J].Am J Cardiol, 2005,95 : 20.
6Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction : a report of the American college of cardiology/American heart association task force on practice( Committee to revise the 1999 Guidelines for the management of patients with acute myocardial infarction ) [ J ]. J Am Coll Cardiol,2004;44 (3) :E1-211.
7Krumholz HM, Pastermak RC, Weinstein MC, et al. Cost effectiveness of thrombolyic with streptokinase in elderly patients with suspected acute myocardial infarction [ J]. N Engl J Med, 1992 ; 327 ( 2 ) : 169 -73.
8Alexander KP, Newby LK, Aimstrong PW, et al. Acute coronary care in the elderly, part Ⅱ : ST-segment-elevation myocardial infarction : a scientific statement for heahhcare professionals from the American Heart Association Council on Clinical Cardiology:in collaboration with the Society of Geriatric Cardiology[J]. Circulation ,2007 ; 115:2570-89.
9Tran cr, Laupacis A, Mamdani MM, et al. Effect of age on the use of evidence-based therapies for acute myocardial infarction [J]. Am Heart J,2004 ; 148:834-41.
10COMMIT Collaborative Group. Addition of clopidogrel to aspirin in45,852 patients with acute myocardial infarction: randomized placebo-controlled trial [ J]. Lancet, 2005 ; 366 ( 9497 ) : 1607 -21.
